These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 10397742)
1. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Schaffner C; Stilgenbauer S; Rappold GA; Döhner H; Lichter P Blood; 1999 Jul; 94(2):748-53. PubMed ID: 10397742 [TBL] [Abstract][Full Text] [Related]
2. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620 [TBL] [Abstract][Full Text] [Related]
3. ATM mutations in B-cell chronic lymphocytic leukemia. Bullrich F; Rasio D; Kitada S; Starostik P; Kipps T; Keating M; Albitar M; Reed JC; Croce CM Cancer Res; 1999 Jan; 59(1):24-7. PubMed ID: 9892178 [TBL] [Abstract][Full Text] [Related]
4. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance. Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464 [TBL] [Abstract][Full Text] [Related]
5. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders. Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446 [TBL] [Abstract][Full Text] [Related]
9. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. Austen B; Skowronska A; Baker C; Powell JE; Gardiner A; Oscier D; Majid A; Dyer M; Siebert R; Taylor AM; Moss PA; Stankovic T J Clin Oncol; 2007 Dec; 25(34):5448-57. PubMed ID: 17968022 [TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia. Ouillette P; Li J; Shaknovich R; Li Y; Melnick A; Shedden K; Malek SN Genes Chromosomes Cancer; 2012 Dec; 51(12):1125-32. PubMed ID: 22952040 [TBL] [Abstract][Full Text] [Related]
11. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Stankovic T; Stewart GS; Fegan C; Biggs P; Last J; Byrd PJ; Keenan RD; Moss PA; Taylor AM Blood; 2002 Jan; 99(1):300-9. PubMed ID: 11756185 [TBL] [Abstract][Full Text] [Related]
12. Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: correlation with clinicobiologic features. Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Milani R; Bardi A; Minotto C; Agostini P; De Angeli C; Narducci MG; Sabbioni S; Russo G; Negrini M; Castoldi G J Clin Oncol; 2000 Jul; 18(13):2607-14. PubMed ID: 10893293 [TBL] [Abstract][Full Text] [Related]
13. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Camacho E; Hernández L; Hernández S; Tort F; Bellosillo B; Beà S; Bosch F; Montserrat E; Cardesa A; Fernández PL; Campo E Blood; 2002 Jan; 99(1):238-44. PubMed ID: 11756177 [TBL] [Abstract][Full Text] [Related]
14. ATM mutations in sporadic lymphoid tumours. Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598 [TBL] [Abstract][Full Text] [Related]
15. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228 [TBL] [Abstract][Full Text] [Related]
16. ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele. Skowronska A; Austen B; Powell JE; Weston V; Oscier DG; Dyer MJ; Matutes E; Pratt G; Fegan C; Moss P; Taylor MA; Stankovic T Haematologica; 2012 Jan; 97(1):142-6. PubMed ID: 21933854 [TBL] [Abstract][Full Text] [Related]
17. Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes. Kalla C; Nentwich H; Schlotter M; Mertens D; Wildenberger K; Döhner H; Stilgenbauer S; Lichter P Genes Chromosomes Cancer; 2005 Feb; 42(2):128-43. PubMed ID: 15543602 [TBL] [Abstract][Full Text] [Related]
18. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106 [TBL] [Abstract][Full Text] [Related]